Healthcare: 2 Hot Biotech Stocks On Our Radar
Industry Focus - Een podcast door The Motley Fool
Categorieën:
How Regenxbio is capitalizing on the emerging gene therapy trend and why Neurocrine Biosciences is on the cusp of making the jump to profitability. Also, how Amarin may revolutionize how doctors treat heart disease. Stocks: RGNX, NVS, NBIX, ABBV, AMRN.
